The molecular basis of epidemic blaKPC Klebsiella pneumoniae and Enterobacteriace

Project Details

Description

DESCRIPTION (provided by applicant): Recent reports indicating a rise in infections caused by carbapenem-resistant Klebsiella pneumoniae (KPC) in the United States and elsewhere have alerted clinicians, infection control teams and public health officials. KPCs typically exhibit a wide spectrum of antimicrobial resistance, and pan-resistance in some cases, thereby severely impacting treatment options and outcomes. A troubling aspect is that the resistance determinant, blaKPC is on a transposon that is harbored on a transmissible plasmid. These resistance bearing plasmids have transmitted to other bacterial genera, such as E. coli. Therefore, it is critical to understand the nature and the genetic basis of spread and the acquisition of these resistance-determining elements. The goal of the present proposal is to determine the role of strains, plasmids, and transposons in the spread and emergence of blaKPC among KPC and other genera. These studies will be done in the New York area, the current epicenter of KPC strains in the US and globally. We will prospectively characterize the nature and extent of the KPC epidemic to examine the molecular epidemiology of infecting isolates over the 5-year project period, including other emerging carbapenem-resistant Enterobacteriaceae. These studies will involve extensive molecular characterization of the isolates, physical and genetic mapping of resistance bearing mobile elements and determinants, as well as evaluating enzyme activity. To determine whether predominant KPC clones or blaKPC-harboring plasmids have unique genomic content or organization we will conduct de novo whole genome sequencing (WGS) of major KPC strains and their plasmids. In addition, in order to examine the evolutionary trajectories (expansion and diversification) of the current epidemic clones we will perform high- throughput comparative WGS of major KPC strains using clone-specific reference strains. The information gained from the molecular epidemiologic studies on KPC strains and carbapenem-resistant Enterobacteriaceae, blaKPC-harboring plasmids, transposons and other resistance determinants will help evaluate the extent to which KPC strains are attributed to primary (clonal) transmission or acquired resistance and whether any new genotypes are emerging in this high incidence region. The results from the genomic studies may help elucidate factors that contribute to the dissemination of predominant clones of KPC that are currently fueling the epidemic. Furthermore, deep molecular dissection of major strains will indicate patterns of genetic diversification and demonstrate clonal emergence. Accomplishing these aims will deepen our understanding of a critical, public health problem by detailing the molecular and genetic characteristics of KPC isolates in the epicenter of a developing crisis;and by examining the lateral transfer of blaKPC genes to other members of Enterobacteriaceae, events that would significantly hinder treatment and infection control programs. These data can inform current and future control strategies and in the development of rapid diagnostics.

PUBLIC HEALTH RELEVANCE: Klebsiella pneumoniae is a Gram negative bacterium that causes urinary tract, pneumoniae and blood stream infections in the hospital setting. The bacteria are commonly antibiotic resistant, but effectively treatable with carbapenems. However, over the last five years New York metropolitan area hospitals have experienced the emergence of carbapenem resistant strains of K. pneumoniae (referred to as KPC strains) and this region has become the global epicenter. KPC strains are extremely difficult to treat and have poor treatment outcomes. It is now known that KPC strains have acquired mobile plasmids harboring a resistance gene referred to as blaKPC which can transfer to other genera of bacteria (Enterobacteriaceae family) rendering them resistant and difficult to treat. The current proposal will collect and genetically analyze KPC strains and other carbapenem resistant Enterobacteriaceae from three large hospitals in New York, Long Island and New Jersey to unravel the molecular epidemiology underpinning this emerging epidemic. The deep molecular dissection will reveal whether the epidemic is the result of a successful resistant clone spreading within and among hospitals or the development of many different resistant strains which are simultaneously spreading;an indication that the resistance gene is readily moving. These studies deepen our understanding of this emerging public health crisis and likely inform control strategies.
StatusActive
Effective start/end date9/29/1011/30/21

Funding

  • National Institute of Allergy and Infectious Diseases: $558,370.00
  • National Institute of Allergy and Infectious Diseases: $1,016,803.00
  • National Institute of Allergy and Infectious Diseases: $564,497.00
  • National Institute of Allergy and Infectious Diseases: $536,305.00
  • National Institute of Allergy and Infectious Diseases: $237,188.00
  • National Institute of Allergy and Infectious Diseases: $991,002.00
  • National Institute of Allergy and Infectious Diseases: $544,800.00
  • National Institute of Allergy and Infectious Diseases: $762,236.00
  • National Institute of Allergy and Infectious Diseases: $647,565.00
  • National Institute of Allergy and Infectious Diseases: $76,308.00
  • National Institute of Allergy and Infectious Diseases: $667,413.00

ASJC

  • Medicine(all)
  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Genetics
  • Molecular Biology
  • Cancer Research
  • Pulmonary and Respiratory Medicine
  • Microbiology

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.